Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gluco-Feed: Food-induced Glucocorticoid Secretion in Healthy Individuals
NCT05167084Phase 1Completed
- Start
- Feb 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of metyrapone and hydrocortisone in obesity. Primary endpoint: Insulin sensitivity at 8 days. Started Feb 2022; status: completed.
02
Drugs
metyraponehydrocortisone
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05167084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05167084.